CClinicalTrials.gg
RecruitingNCT06048965Updated Nov 8, 2023

Asia Pacific Menopause Federation Menopause Consensus

An observational study in Menopause and Menopause Related Conditions, sponsored by Singapore General Hospital. Recruiting at 1 site in Singapore. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-08.

Sponsored by Singapore General Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years ago, but the record still lists the study as recruiting.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
21 Years and older
Sex
All
01

Study summary

The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific

Read the detailed description

The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific. The experience of the menopause is deeply rooted in sociocultural perceptions unique to each population. Thus, the management of menopausal symptoms and other conditions related to the menopause also vary from region to region.

The investigators will use a modified Delphi method involving the participation of experts from various countries in the Asia-Pacific. The objective of this study is to achieve consensus on various aspects of the management of the menopause in the Asia-Pacific.

This study will involve several rounds of Delphi surveys, administered via Google Forms, Microsoft Word or PDF. Each survey questionnaire contains

  1. Questions on basic demographic information
  2. Statements on areas of concern in the management of the menopause; each participants vote on to what extent they agree or disagree with the statement on a Likert scale.
  3. Questions on the participants' usual clinical practice in treating menopause Multiple survey rounds will be held until agreement on the statements and stability is achieved.
02

Conditions studied

  • Menopause
  • Menopause Related Conditions
03

In context

Lead sponsor

Singapore General Hospital is the lead sponsor of 266 studies on the registry; 57 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Physicians with experience in treating menopause

Eligibility criteria

Inclusion Criteria:

Experience in treating menopause

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Expert group

    Other: No intervention to be performed

Interventions

  • OtherNo intervention to be performed

    No intervention to be performed. Anonymous survey only.

06

What researchers measure

Primary outcomes

  1. Percentage of participants who vote for the same option on a series of survey questions

    Time frame: 2023-2024

07

Study locations

1 of 1 sites recruiting
  • Singapore General Hospital
    Singapore, Singapore
    • Felicia C Tan, MBBChir · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06048965
Lead sponsor
Singapore General Hospital
Responsible party
Sponsor
First posted
Sep 21, 2023
Start date
Nov 20, 2023 (estimated)
Primary completion
Sep 15, 2024 (estimated)
Completion
Mar 15, 2025 (estimated)
Last update
Nov 8, 2023

Study contacts

Felicia Tan, MB BChir
Contact
felicia.clara.tan@gmail.com
82511939

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion